Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

UBS upgrades RBS to 'buy' after dividend restart and US DoJ settlement

UBS raised its rating on RBS to ‘buy’ from ‘neutral’ and lifted its target price to 300p from 285p
RBS
UBS estimates a dividend yield of 3.4% in 2018, rising to 5.0% in 2020

The sins of Royal Bank of Scotland Group PLC’s (LON:RBS) past are largely behind the lender, UBS said, as it turned positive on the stock.

UBS raised its rating on the stock to ‘buy’ from ‘neutral’ and lifted its target price to 300p from 285p after RBS earlier this month announced its first dividend since it was bailed out by the government in 2008 during the financial crisis.

READ: RBS shares rise as it looks to pay first dividend since financial crisis, posts first half profit

A US$4.9bn settlement with the US Department of Justice (DoJ) over the sale of mortgage-backed securities in the run-up to the financial crisis, marked the last of the bank’s major legacy issues and paved the way for the resumption of dividends.

RBS recommended an interim dividend of 2p as it reported an attributable profit of £888mln for the six months ended June 30, down from £939mln last year, with the decline reflecting its settlement with the DoJ.

“The first dividend in a decade didn't dent the balance sheet either: significant special dividends or buybacks – perhaps direct from government – are needed to stop this undervalued surplus capital from growing further,” UBS said.

“We think earnings and excess capital are undervalued at a buyback-adjusted medium term price-earnings of 6-7x; upgrade to Buy.”

UBS expects higher dividend yield, share buybacks

RBS is targeting earnings per share (EPS) of 34p in 2020 and while UBS is “more cautious” with its estimate of 28p, it expects £5bn in share buybacks to the end of 2021 to take the stock to 6.5 times earnings.

UBS estimates a dividend yield of 3.4% in 2018, rising to 5.0% in 2020, along with buybacks and special dividends to reduce overcapitalisation.

In 2019, UBS expects RBS to ask shareholders for approval to repurchase stock direct from the UK government, reducing the overhang, increasing index weights and delivering EPS accretion.

The government sold 925mln of its shares in RBS in June, reducing its stake to 62.4% from 70.1%.

Risk of no-deal Brexit 

With any company, there are of course risks, and a no-deal Brexit scenario is a major one facing RBS.

“If negotiations fail we would expect pressure from margins (Bank of England to cut rates and restart quantitative easing), loan losses (lower house prices, weaker macro-economic assumptions under IFRS 9) and higher risk-weighted assets density,” UBS said.

“We don't kid ourselves that discounted valuations would provide protection. But a no-deal Brexit is also not our base case given significant apparent risks to financial stability for both sides of the negotiating table: we see room for UK domestic bank exposure in any portfolio.” 

View full RBS profile View Profile

Royal Bank of Scotland Timeline

Related Articles

1524578583_cannabis-plants.jpg
April 24 2018
Redfund is positioning itself to become a top-tier cannabis incubator and accelerator

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use